Sign In/Register 0

We use cookies, check our Privacy Policies.

eEF2K (Phospho-Ser359) Antibody

Catalog No : A8340
  • Reactivity
    Human,Mouse,Rat
  • Applications
    IHC-p,IF(paraffin section),ELISA
  • Modification
    Phospho Specific
  • Source
    Polyclonal Rabbit
  • Storage and Stability
    -20°C/1 year
  • Size
    50 μl
  • Price/Quantity
    $205
  • Quantity
Details
  • Product Name
    eEF2K (Phospho-Ser359) Antibody
  • Description
    This gene encodes a highly conserved protein kinase in the calmodulin-mediated signaling pathway that links activation of cell surface receptors to cell division. This kinase is involved in the regulation of protein synthesis. It phosphorylates eukaryotic elongation factor 2 (EEF2) and thus inhibits the EEF2 function. The activity of this kinase is increased in many cancers and may be a valid target for anti-cancer treatment. [provided by RefSeq, Jul 2008]
  • Catalog No
    A8340
  • Reactivity
    Human, Mouse, Rat
  • Applications
    IHC-p, IF(paraffin section), ELISA
  • Modification
    Phospho Specific
  • Source
    Polyclonal Rabbit
  • Dilution
    Immunohistochemistry: 1/100 - 1/300. ELISA: 1/20000. Not yet tested in other applications.
  • Purification
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
  • Concentration
    1 mg/ml
  • Storage and Stability
    -20°C/1 year
  • Other Name
    EEF2K; Eukaryotic elongation factor 2 kinase; eEF-2 kinase; eEF-2K; Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase
  • Molecular Weight (Da)
    82172
  • Gene Name
    EEF2K
  • Protein Name
    Eukaryotic elongation factor 2 kinase
  • Human Gene ID
    29904
  • Human Swiss Prot No.
    O00418
  • Immunogen
    The antiserum was produced against synthesized peptide derived from human eEF2K around the phosphorylation site of Ser359. AA range:336-385
  • Specificity
    Phospho-eEF2K (S359) Polyclonal Antibody detects endogenous levels of eEF2K protein only when phosphorylated at S359.
  • Formulation
    Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.